MAC VS DOC Stock Comparison

PerformanceAnalyst Price TargetsTechnicalsEarningsProfitVolatilityDividend
PerformanceAnalyst Price TargetsTechnicalsEarningsProfitVolatilityDividend

Performance

MAC
37/100

MAC returned -11.98% in the last 12 months. Based on SPY's performance of -10.63%, its performance is below average giving it a score of 37 of 100.

DOC
10/100

DOC returned -16.64% in the last 12 months. Based on SPY's performance of 15.17%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

MAC
57/100

19 analysts offer 12-month price targets for MAC. Together, they have an average target of 15.33, the most optimistic target put MAC at 19 within 12-months and the most pessimistic has MAC at 11.

DOC
76/100

17 analysts offer 12-month price targets for DOC. Together, they have an average target of 17.7, the most optimistic target put DOC at 20 within 12-months and the most pessimistic has DOC at 15.

Technicals

MAC
86/100

MAC receives a 85 of 100 based on 14 indicators. 11 are bullish, 1 are bearish.

DOC
50/100

DOC receives a 50 of 100 based on 14 indicators. 6 are bullish, 6 are bearish.

Earnings

MAC
10/100

MAC has missed earnings 14 times in the last 20 quarters.

DOC
10/100

DOC has missed earnings 6 times in the last 20 quarters.

Profit

MAC
34/100

Out of the last 20 quarters, MAC has had 9 profitable quarters and has increased their profits year over year on 3 of them.

DOC
72/100

Out of the last 20 quarters, DOC has had 20 profitable quarters and has increased their profits year over year on 8 of them.

Volatility

MAC
45/100

MAC has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.

DOC
46/100

DOC has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.

Dividend

MAC
10/100

MAC's most recent dividend was $0.81 per share, based on a share price of $11.39. It was a payout ratio of 971.92% compared to their total earnings.

DOC
10/100

DOC's most recent dividend was $0.23 per share, based on a share price of $11.67. It was a payout ratio of 404.21% compared to their total earnings.

All score calculations are broken down here to help you make more informed investing decisions

The Macerich Company Summary

New York Stock Exchange / MAC
Real Estate
REIT - Retail
Macerich is a fully integrated, self-managed and self-administered real estate investment trust, which focuses on the acquisition, leasing, management, development and redevelopment of regional malls throughout the United States. Macerich currently owns 51 million square feet of real estate consisting primarily of interests in 47 regional shopping centers. Macerich specializes in successful retail properties in many of the country's most attractive, densely populated markets with significant presence in the West Coast, Arizona, Chicago and the Metro New York to Washington, DC corridor. A recognized leader in sustainability, Macerich has achieved the #1 GRESB ranking in the North American Retail Sector for five straight years (2015 – 2019).

Healthpeak Properties, Inc. Summary

New York Stock Exchange / DOC
Real Estate
REIT - Healthcare Facilities
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.